| Primary |
| Menopausal Symptoms |
36.9% |
| Hormone Replacement Therapy |
30.9% |
| Hormone Therapy |
8.3% |
| Ill-defined Disorder |
5.7% |
| Menopause |
5.1% |
| Hot Flush |
4.0% |
| Drug Use For Unknown Indication |
2.3% |
| Hypertension |
1.0% |
| Postmenopausal Haemorrhage |
0.8% |
| Product Used For Unknown Indication |
0.8% |
| Depression |
0.6% |
| Menstruation Irregular |
0.6% |
| Osteoporosis |
0.6% |
| Menorrhagia |
0.5% |
| Blood Cholesterol Increased |
0.4% |
| Diabetes Mellitus Insulin-dependent |
0.4% |
| Thyroid Disorder |
0.4% |
| Anticoagulant Therapy |
0.3% |
| Arthritis |
0.3% |
| Atrophic Vulvovaginitis |
0.3% |
|
| Breast Cancer |
70.1% |
| Breast Cancer In Situ |
6.1% |
| Breast Cancer Metastatic |
3.7% |
| Breast Cancer Female |
3.3% |
| Endometrial Cancer |
2.8% |
| Progesterone Receptor Assay Positive |
1.9% |
| Benign Breast Neoplasm |
1.4% |
| Myocardial Infarction |
1.4% |
| Venous Thrombosis |
1.4% |
| Breast Cancer Stage I |
0.9% |
| Breast Mass |
0.9% |
| Metastases To Liver |
0.9% |
| Oestrogen Receptor Assay Positive |
0.9% |
| Papillary Serous Endometrial Carcinoma |
0.9% |
| Scleroderma |
0.9% |
| Alopecia |
0.5% |
| Blood Glucose Decreased |
0.5% |
| Breast Cancer Stage Ii |
0.5% |
| Breast Pain |
0.5% |
| Breast Swelling |
0.5% |
|
| Secondary |
| Hormone Replacement Therapy |
85.0% |
| Menopausal Symptoms |
7.9% |
| Hot Flush |
1.3% |
| Menopause |
0.7% |
| Blood Cholesterol Increased |
0.6% |
| Oestrogen Replacement Therapy |
0.5% |
| Depression |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Ill-defined Disorder |
0.3% |
| Hormone Therapy |
0.3% |
| Menorrhagia |
0.3% |
| Thyroid Disorder |
0.3% |
| Hypothyroidism |
0.3% |
| Anxiety |
0.2% |
| Osteoporosis |
0.2% |
| Arthritis |
0.2% |
| Hypertension |
0.2% |
| Migraine |
0.2% |
| Urticaria |
0.2% |
| Blood Cholesterol |
0.2% |
|
| Breast Cancer |
39.3% |
| Breast Cancer Female |
35.5% |
| Breast Cancer Metastatic |
11.9% |
| Breast Disorder |
1.4% |
| Pain |
1.4% |
| Breast Cancer In Situ |
1.2% |
| Progesterone Receptor Assay Positive |
1.2% |
| Uterine Leiomyoma |
1.0% |
| Benign Breast Neoplasm |
0.8% |
| Myocardial Infarction |
0.8% |
| Vomiting |
0.8% |
| Breast Cancer Recurrent |
0.6% |
| Lymphoedema |
0.6% |
| Neoplasm Malignant |
0.6% |
| Scleroderma |
0.6% |
| Surgery |
0.6% |
| Walking Aid User |
0.6% |
| Cerebrovascular Accident |
0.4% |
| Depression |
0.4% |
| Metastases To Lymph Nodes |
0.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
47.0% |
| Drug Use For Unknown Indication |
9.0% |
| Hormone Replacement Therapy |
6.6% |
| Depression |
4.5% |
| Osteoporosis |
3.7% |
| Rheumatoid Arthritis |
3.2% |
| Osteopenia |
3.1% |
| Smoking Cessation Therapy |
2.6% |
| Pain |
2.4% |
| Back Pain |
1.9% |
| Insomnia |
1.9% |
| Neoplasm Malignant |
1.9% |
| Type 1 Diabetes Mellitus |
1.9% |
| Anxiety |
1.6% |
| Bipolar Disorder |
1.5% |
| Crohn's Disease |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Hypertension |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Colorectal Cancer |
1.3% |
|
| Vomiting |
12.8% |
| Vision Blurred |
11.9% |
| Weight Increased |
11.0% |
| Vitreous Floaters |
8.3% |
| Headache |
6.4% |
| Fatigue |
4.6% |
| Pain |
4.6% |
| Therapy Non-responder |
4.6% |
| Nausea |
3.7% |
| Somnolence |
3.7% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Arthropathy |
2.8% |
| Constipation |
2.8% |
| Drug Ineffective |
2.8% |
| Palpitations |
2.8% |
| Paraesthesia |
2.8% |
| Soft Tissue Necrosis |
2.8% |
| Stress |
2.8% |
| Unevaluable Event |
2.8% |
| Weight Decreased |
2.8% |
|
